BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12812622)

  • 1. Collaborative partnership for optimizing heart failure outcomes in the long-term care environment: a clinical experience.
    Polakoff D; Tuell K; Floyd K; Collette A; Wolfe M
    J Am Med Dir Assoc; 2000; 1(5):217-22. PubMed ID: 12812622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical pathway for the management of acute heart failure at the Veterans Affairs San Diego Healthcare System: transforming performance measures into cardiac care.
    Gardetto NJ; Greaney K; Arai L; Brenner A; Carroll KC; Howerton NM; Lee M; Pada L; Tseng M; Maisel AS
    Crit Pathw Cardiol; 2008 Sep; 7(3):153-72. PubMed ID: 18791404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
    Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
    Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design.
    Fonarow GC; Abraham WT; Albert NM; Gattis WA; Gheorghiade M; Greenberg B; O'Connor CM; Yancy CW; Young J
    Am Heart J; 2004 Jul; 148(1):43-51. PubMed ID: 15215791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How well are chronic heart failure patients being managed?
    Fonarow GC
    Rev Cardiovasc Med; 2006; 7 Suppl 1():S3-11. PubMed ID: 16955055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of long-term benefits of a 6-month heart failure disease management program.
    Nguyen V; Ducharme A; White M; Racine N; O'Meara E; Zhang B; Rouleau JL; Brophy J
    J Card Fail; 2007 May; 13(4):287-93. PubMed ID: 17517349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of neurohormonal antagonists in reducing heart failure hospitalizations.
    Williams RE
    Curr Med Res Opin; 2006 Jan; 22(1):139-50. PubMed ID: 16393440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, controlled evaluation of short- and long-term benefits of heart failure disease management within a diverse provider network: the SPAN-CHF trial.
    Kimmelstiel C; Levine D; Perry K; Patel AR; Sadaniantz A; Gorham N; Cunnie M; Duggan L; Cotter L; Shea-Albright P; Poppas A; LaBresh K; Forman D; Brill D; Rand W; Gregory D; Udelson JE; Lorell B; Konstam V; Furlong K; Konstam MA
    Circulation; 2004 Sep; 110(11):1450-5. PubMed ID: 15313938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term healthcare and cost outcomes of disease management in a large, randomized, community-based population with heart failure.
    Galbreath AD; Krasuski RA; Smith B; Stajduhar KC; Kwan MD; Ellis R; Freeman GL
    Circulation; 2004 Dec; 110(23):3518-26. PubMed ID: 15531765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new programme of multidisciplinary care for patients with heart failure in Poznań: one-year follow-up.
    Wierzchowiecki M; Poprawski K; Nowicka A; Kandziora M; Piatkowska A; Jankowiak M; Michałowicz B; Stawski W; Dziamska M; Kaszuba D; Szymanowska K; Michalski M
    Kardiol Pol; 2006 Oct; 64(10):1063-70; discussion 1071-2. PubMed ID: 17089238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dental screening and referral of young children by pediatric primary care providers.
    dela Cruz GG; Rozier RG; Slade G
    Pediatrics; 2004 Nov; 114(5):e642-52. PubMed ID: 15520094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH).
    Jaarsma T; van der Wal MH; Lesman-Leegte I; Luttik ML; Hogenhuis J; Veeger NJ; Sanderman R; Hoes AW; van Gilst WH; Lok DJ; Dunselman PH; Tijssen JG; Hillege HL; van Veldhuisen DJ;
    Arch Intern Med; 2008 Feb; 168(3):316-24. PubMed ID: 18268174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies to improve the use of evidence-based heart failure therapies.
    Fonarow GC
    Rev Cardiovasc Med; 2005; 6 Suppl 2():S32-42. PubMed ID: 15891703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of in-hospital initiation of evidence-based medical therapies for heart failure-a review.
    Fonarow GC; Gheorghiade M; Abraham WT
    Am J Cardiol; 2004 Nov; 94(9):1155-60. PubMed ID: 15518610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies to improve the use of evidence-based heart failure therapies: OPTIMIZE-HF.
    Fonarow GC
    Rev Cardiovasc Med; 2004; 5 Suppl 1():S45-54. PubMed ID: 15184838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Outpatient medical and nurse management program in patients with chronic heart failure in a large territorial area in Piedmont. Four years of follow-up].
    Conte MR; Mainardi L; Iazzolino E; Casetta M; Asteggiano R; Lai F; Lusardi R; Sasso L
    Ital Heart J Suppl; 2005 Dec; 6(12):812-20. PubMed ID: 16444925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF).
    Fonarow GC; Abraham WT; Albert NM; Gattis Stough W; Gheorghiade M; Greenberg BH; O'Connor CM; Pieper K; Sun JL; Yancy CW; Young JB;
    Arch Intern Med; 2007 Jul; 167(14):1493-502. PubMed ID: 17646603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival after heart failure: a contemporary population-based perspective.
    Goldberg RJ; Ciampa J; Lessard D; Meyer TE; Spencer FA
    Arch Intern Med; 2007 Mar; 167(5):490-6. PubMed ID: 17353497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    Greenberg BH; Abraham WT; Albert NM; Chiswell K; Clare R; Stough WG; Gheorghiade M; O'Connor CM; Sun JL; Yancy CW; Young JB; Fonarow GC
    Am Heart J; 2007 Aug; 154(2):277.e1-8. PubMed ID: 17643576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TEACH: Trial of Education And Compliance in Heart dysfunction chronic disease and heart failure (HF) as an increasing problem.
    Gwadry-Sridhar F; Guyatt G; O'Brien B; Arnold JM; Walter S; Vingilis E; MacKeigan L
    Contemp Clin Trials; 2008 Nov; 29(6):905-18. PubMed ID: 18703166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.